Page last updated: 2024-08-24

topotecan and Cystadenocarcinoma, Mucinous

topotecan has been researched along with Cystadenocarcinoma, Mucinous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bădulescu, A; Bădulescu, F; Popescu, CF; Schenker, M; Stoica, Z	1

Other Studies

1 other study(ies) available for topotecan and Cystadenocarcinoma, Mucinous

Article	Year
The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2005, Volume: 46, Issue:4 Topics: CA-125 Antigen; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Topotecan; Treatment Outcome	2005

Article

Year

The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2005, Volume: 46, Issue:4

Topics: CA-125 Antigen; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Topotecan; Treatment Outcome

2005